These articles discussed how GLP-1 RA uses the effect of delayed gastric emptying, the half-lives of these medications, and increased RGC and pulmonary aspiration risk
Education covers device type, storage, mixing when applicable, and safe needle disposal so home use is consistent

Glucagon-like peptide 1 receptor agonists for type 2 diabetes, Diabetes Spectrum (2017) With Trulicity, patients may be able to lose some weight, Eli Lilly Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11), Diabetes Care (2021) Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial, Lancet Diabetes Endocrinology (2017) Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial, Lancet (2014) Efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes in a randomized controlled trial (AWARD-3), Diabetes Care (2014) Mounjaro prescribing information, Eli Lilly Beyond glycemia: Comparing tirzepatide to GLP-1 analogues, Reviews in Endocrine and Metabolic Disorders (2023) Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial, Lancet Diabetes Endocrinology (2022) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Open communication ensures that your treatment goals remain aligned with your overall health and quality of life
Structured stress reduction practices complement peptide protocols by reducing the inflammatory and barrier-disrupting effects of chronic psychological stress